Although neutrophilia can manifest from various causes, it is important to be able to distinguish chronic neutrophilic leukemia (CNL) from neutrophilic leukemoid reactions (NLR). In this paper, we describe four cases of leukocytosis with neutrophilia, including one case of CNL with a T618I mutation in colony stimulating factor 3 receptor (CSF3R) and three cases of NLR associated with malignancy or sepsis, which were initially suspected as CNL. Of the three NLR cases, one was associated with ovarian cancer, one with monoclonal gammopathy of undetermined significance and one with multiple myeloma with sepsis. This study demonstrated that confirming the clonality of myeloid cells with CSF3R T618I could contribute to making an accurate differential diagnosis between CNL and NLR in patients with solid cancers or plasma cell neoplasms caused by paraneoplastic syndromes and/or infection.
eISSN 2093-6338 liferative neoplasm associated with a mutation in the colony stimulating factor 3 receptor (CSF3R) gene [3] . The protein encoded by this gene is the receptor for colony stimulating factor 3 that produces a signal through downstream SRC family kinases and Janus kinase (JAK) pathways and plays an important role in the growth and differentiation of granulocytes [4] . There are two different classes of CSF3R mutation: One is a truncation mutation, which results in dysregulation of downstream SRC family kinases and leads to constitutive overexpression of the receptor and ligand hypersensitivity. The other is a membrane proximal mutation which results in dysregulation of the JAK family and constitutive activation of the receptor in the absence of granulocyte-colony stimulating factor (G-CSF) ligand [4] . An example of the membrane proximal mutation is on exon 14 of CSF3R resulting in T618I mutation, which has been identi ed in more than 80% of CNL cases [3] . CSF3R T618I could be used as a molecular marker to make a differential diagnosis between CNL and NLR. It has been reported that NLR can develop in 10% of patients with solid tumors (lung, Neutrophilia can occur due to chronic neutrophilic leukemia (CNL) or neutrophilic leukemoid reaction (NLR) associated with infection, neoplasm, in ammation, drug use, and acute hemorrhaging, among other causes [1, 2] [1, 2] , and may be due to the paraneoplastic production of G-CSF or other growth factors. Furthermore, NLR can be present years before the diagnosis of carcinoma [5] . A few studies have reported that CNL or NLR can occur in plasma cell neoplasms [6, 7] .
Here, we describe one CNL case and three NLR cases initially suspected of being CNL that were associated with solid cancers, plasma cell neoplasms or sepsis.
We retrospectively reviewed the database of bone marrow (BM) study patients from January 2014 to October 2016 and identi ed four patients with leukocytosis of more than 25×10 9 /L and neutrophilia without left shift (more than 80% of segmented neutrophils). We performed a CSF3R mutation assay to help differentiate between CNL and NLR. DNA was extracted from BM aspirates, and a polymerase chain reaction (PCR) and Sanger sequencing were performed using primers for the T618I mutation on CSF3R exon 14 according to a previous study [3] : forward 5′-CCACGGAG-GCAGCTTTAC-3′ and reverse 5′-AAATCAGCATCCTTTGGGTG-3′, which revealed an ACC to ATC mutation corresponding to the T618I mutation of CSF3R.
The clinical and laboratory ndings of the four patients are shown in Table 1 and Fig. 1 . The rst patient (case 1) tested positive for CNL with CSF3R T618I. Three patients (cases 2 to 4) showed negative results for CSF3R T618I and the cause of NLR was associated with ovarian cancer, monoclonal gammopathy of undetermined signi cance (MGUS), and multiple myeloma (MM) with sepsis, respectively.
One patient (case 1) presented hypovolemic shock and had a history of chronic kidney disease, hypertension, and persistent leukocytosis, which had lasted for more than four months (22-61 or the CSF3R mutation (2341_2342insC; cytoplasmic domain) on exon 17 could be associated with CNL [3, 16] . In addition, in CNL patients without the CSF3R T618I mutation, mutations in other genes such as ASXL1, TET2, SRSF2, JAK2, and SETBP1 have also been reported [3, 7] . It would be helpful to examine the mutations mentioned above as well as the CSF3R T618I mutation to determine clonality, but we could not perform them.
Some studies have reported that CNL can co-occur with plasma cell neoplasm [3, 6, 17] although most cases did not con rm the clonality of neutrophils [6, 7] . It remains unclear whether neutrophilic leukocytosis is a leukemoid response caused by cytokine release such as interleukin-6 by neoplastic plasma cells or independent clonal disorders. One study has shown that about a quarter of patients with neutrophilia have coexisting MM or MGUS [7] .
In case 4, the patient was transferred to our emergency room because of septic shock accompanied by extreme leukocytosis 
AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
No potential con icts of interest relevant to this article were reported.
